InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3064% above fair value
$9.47+0.07 (+0.74%)
Close on Nov 13, 2026Market cap $1.29BP/E –Yield –
InnovAge ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
InnovAge's ebitda for the twelve months ending Jun 30, 2026 was $23.76M. For fiscal 2026 it was $23.76M. The highest annual figure on record is $62.22M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $23.76M | – |
| FY2025 | Jun 30, 2025 | -$10.25M | – |
| FY2024 | Jun 30, 2024 | -$4.23M | – |
| FY2023 | Jun 30, 2023 | -$33.98M | -457.0% |
| FY2022 | Jun 30, 2022 | $9.52M | – |
| FY2021 | Jun 30, 2021 | -$43.00K | -100.1% |
| FY2020 | Jun 30, 2020 | $62.22M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $16.50M | +1226.5% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$24.26M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $18.14M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $13.37M | +2501.9% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.24M | +178.9% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$4.77M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$7.24M | -388.9% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $514.00K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $446.00K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$731.00K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $2.51M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$6.45M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$6.61M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$4.18M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$10.02M | -260.4% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$13.17M | -188.1% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$8.86M | -164.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$2.82M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $6.25M | -73.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $14.95M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $13.70M | -40.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$2.06M | -113.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $23.53M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$35.22M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $23.15M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $15.74M | – |
See a number that looks wrong?